A Global and National Voice on Women's Health
The United Nations Annual Ideagen Summit invited Dr. Mazure to speak on the value of research in improving the health of women and ensuring economic security and advancement of families as part of “Empowering Women & Girls 2030.”
Dr. Mazure advanced the international imperative to improve women’s health with presentations in France at the University of Bordeaux and the Sorbonne and has helped to determine funding for biomedical grant applications internationally on the health of women for a variety of countries, including Canada, the Netherlands, and Austria.
Contributions also include providing research data for the global conversations on common, devastating disorders affecting women, such as Alzheimer’s Disease (The Lancet Neurology), cardiovascular disease (Cell), and opioid misuse (The Journal of the Federation of American Societies for Experimental Biology).
WHRY provides ongoing consultation to state and federal legislators responsible for decisions on biomedical research funding and health care planning.
As a member of the NIH Office for Research on Women’s Health Advisory Committee, the Director of Women’s Health Research at Yale has had a direct line into the national discourse on contemporary research in this field and into the data stream on the health of women provided to communities across the nation.
Dr. Mazure has provided testimony to the U.S. Congress on the value of research on the health of women. She has provided consultation on sex and gender differences in health research to U.S. government agencies as well as to professional medical societies and scientific journals.
WHRY has been a model for diversity, equity, inclusion, and a sense of belonging (DEIB) for the past 25 years. The center stresses the importance of DEIB by funding research projects designed to ensure health equity for all women, while drawing attention to the influence diverse social variables have on health outcomes.